FLAIR hyperintense cortical lesions in anti-myelin oligodendrocyte glycoprotein antibody-associated encephalitis with seizure following SARS-CoV-2 mRNA vaccination

Fumitaka Yoshino; Yuichi Ozaki; Tomoya Shibahara; Mikiaki Matsuoka; Masaki Tachibana; Tetsuro Ago; Takanari Kitazono; Junya Kuroda; Hiroshi Nakane

doi:10.1016/j.ensci.2023.100492

FLAIR hyperintense cortical lesions in anti-myelin oligodendrocyte glycoprotein antibody-associated encephalitis with seizure following SARS-CoV-2 mRNA vaccination

eNeurologicalSci. 2023 Dec 22:34:100492. doi: 10.1016/j.ensci.2023.100492. eCollection 2024 Mar.

Authors

Fumitaka Yoshino^{1

2}, Yuichi Ozaki¹, Tomoya Shibahara¹, Mikiaki Matsuoka¹, Masaki Tachibana¹, Tetsuro Ago², Takanari Kitazono², Junya Kuroda¹, Hiroshi Nakane¹

Affiliations

¹ Department of Neurology, National Hospital Organization Fukuokahigashi Medical Center, Japan.
² Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Japan.

No abstract available

Keywords: Anti-myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD); FLAIR-hyperintense lesions in anti-MOG-associated encephalitis with seizures (FLAMES); Severe acute respiratory syndrome coronavirus 2; Vaccination.